CME Income Tax Expense from 2010 to 2024

CME Stock  USD 206.23  3.27  1.56%   
CME's Income Tax Expense is increasing over the years with slightly volatile fluctuation. Overall, Income Tax Expense is expected to go to about 973.8 M this year. During the period from 2010 to 2024 CME Income Tax Expense annual values regression line had geometric mean of  479,309,112 and mean square error of 379803.8 T. View All Fundamentals
 
Income Tax Expense  
First Reported
2001-03-31
Previous Quarter
224.1 M
Current Value
191.4 M
Quarterly Volatility
277.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME main balance sheet or income statement drivers, such as Depreciation And Amortization of 370.2 M, Interest Expense of 107.7 M or Selling And Marketing Expenses of 171 M, as well as many exotic indicators such as Price To Sales Ratio of 8.04, Dividend Yield of 0.0237 or PTB Ratio of 3.8. CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
  
This module can also supplement CME's financial leverage analysis and stock options assessment as well as various CME Technical models . Check out the analysis of CME Correlation against competitors.

Latest CME's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of CME Group over the last few years. It is CME's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CME's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

CME Income Tax Expense Regression Statistics

Arithmetic Mean502,655,400
Geometric Mean479,309,112
Coefficient Of Variation124.04
Mean Deviation390,174,027
Median709,800,000
Standard Deviation623,499,166
Sample Variance388751.2T
Range2.5B
R-Value0.30
Mean Square Error379803.8T
R-Squared0.09
Significance0.27
Slope42,471,296
Total Sum of Squares5442516.9T

CME Income Tax Expense History

2024973.8 M
2023927.4 M
2022799.3 M
2021736.7 M
2020615.7 M
2019573.8 M
2018814.1 M

About CME Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include CME income statement, its balance sheet, and the statement of cash flows. CME investors use historical funamental indicators, such as CME's Income Tax Expense, to determine how well the company is positioned to perform in the future. Although CME investors may use each financial statement separately, they are all related. The changes in CME's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CME's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CME Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CME. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Tax Expense927.4 M973.8 M

Pair Trading with CME

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.

Moving together with CME Stock

  0.87ICE Intercontinental Exchange Financial Report 2nd of May 2024 PairCorr

Moving against CME Stock

  0.73DHIL Diamond Hill InvestmentPairCorr
  0.68FG FG Annuities Life Financial Report 1st of May 2024 PairCorr
  0.62BY Byline Bancorp Report 25th of April 2024 PairCorr
  0.58SPGI SP Global Financial Report 25th of April 2024 PairCorr
  0.51VALU Value LinePairCorr
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out the analysis of CME Correlation against competitors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.276
Dividend Share
4.4
Earnings Share
8.87
Revenue Per Share
15.512
Quarterly Revenue Growth
0.192
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.